Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 4.4% – Still a Buy?

Anbio Biotechnology (NASDAQ:NNNN)’s stock price traded up 4.4% during trading on Wednesday . The stock traded as high as $8.00 and last traded at $8.1750. Approximately 7,010 shares were traded during trading, a decline of 87% from the average session volume of 55,502 shares. The stock had previously closed at $7.83.

Wall Street Analyst Weigh In

Separately, Weiss Ratings lowered Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

Anbio Biotechnology Trading Up 0.8%

The business has a fifty day moving average of $10.69 and a 200-day moving average of $20.13.

Anbio Biotechnology Company Profile

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.